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In order to investigate the possible role of dogs and cats in the carriage and 
potential dissemination of resistant enterococci, seventy faecal samples from dogs 
and cats were tested for enterococci. Fifty-eight enterococci were recovered. Iso-
lates were identified as Enterococcus faecium (n = 31) and E. faecalis (n = 14) E. 
durans (n = 6), E. casseliflavus (n = 2), E. hirae and E. gallinarum (2 isolates each). 
Enterococcal isolates showed resistance to ciprofloxacin (n = 35), erythromycin 
(n = 31), tetracycline (n = 25), kanamycin (n = 15), streptomycin (n = 13), pristi-
namycin (n = 11), gentamicin (n = 10), chloramphenicol (n = 8), and linezolid 
(n = 6). The gene erm(B) was detected in 22 out of 31 erythromycin-resistant en-
terococci. All tetracycline-resistant enterococci carried tet(M) and/or tet(L) genes. 
The gene aac(6’)-Ie-aph(2”)-Ia was identified in five of high-level gentamicin-
resistant isolates, the genes aph(3’)-IIIa and/or aac(6’)-Ie-aph(2”)-Ia in eleven 
high-level kanamycin-resistant isolates and the gene ant(6)-Ia in eleven high-level 
streptomycin-resistant isolates. Only one strain harboured cat(A) gene, and five 
strains contained vat(E) or vat(D) genes. Virulence genes gel(E) (21 strains), esp 
(11 strains) and cylA/cylB (5 strains) were detected. High genetic diversity was 
demonstrated among E. faecium isolates by pulsed-field gel electrophoresis (PFGE). 
Dogs and cats can be carriers of antibiotic-resistant enterococci in their faeces that 
could shed into the household environment. 
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resistance 
Antibiotic-resistant bacteria have been increasingly detected in different 
habitats, mainly as a result of the intensive use of antimicrobial agents in human 
and veterinary medicine (Leite-Martins et al., 2015). 
Enterococci are part of the normal intestinal microbiota of humans and 
animals, although they can also be opportunistic pathogens, causing different 
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types of infections (Fisher and Phillips, 2009; Byappanahalli et al., 2012). En-
terococci can easily acquire antimicrobial resistance through mutations or acqui-
sition of antimicrobial resistance genes included in plasmids and transposons (Da 
Costa et al., 2013; Gilmore et al., 2013). 
Cats and dogs are companion animals that have been in close contact with 
humans since ancient times, which makes possible the transfer of bacteria be-
tween these animals and their owners (Guardabassi et al., 2004; Lloyd, 2007). 
There are numerous reports that describe pet animals (cats and dogs) as reser-
voirs of antimicrobial resistance determinants for many pathogens and commen-
sals, including staphylococci, enterococci, Escherichia coli, and Salmonella 
(Rodrigues et al., 2002; Guardabassi et al., 2004; Buma et al., 2006; Lloyd, 2007; 
Leite-Martins et al., 2014). The widespread use of antimicrobials in these animals 
favours the increase of resistance and exerts a selection pressure on commensal 
microorganisms of their intestinal tract (Guardabassi et al., 2004; Lloyd, 2007). 
Some previous studies have analysed the presence of enterococci in 
healthy dogs and cats (Poeta et al., 2006; Delgado et al., 2007; Jackson et al., 
2009; Kataoka et al., 2014; Leite-Martins et al., 2015). However, none of these 
studies have been performed in African countries. The objective of this study 
was to determine the carriage rate of enterococci in the faeces of a population of 
healthy dogs and cats in Tunisia (at a single point in time), by analysing the an-
timicrobial resistance phenotypes and genotypes as well as the virulence factors 
of the isolates recovered. 
 
Materials and methods 
Samples and bacterial strains 
Faecal swabs were collected from 70 healthy pets (20 cats and 50 dogs) 
from March through June 2016. Samples were taken at three veterinary clinics 
located in the northern suburbs of Tunis during routine consultations, and they 
were immediately transported under refrigeration to the University of Tunis for 
analysis. The owners of the dogs and cats gave their informed consent to their 
animals’ participation in the study. Samples were obtained by veterinarians who 
wore gloves during sample collection, following the local regulations. All 
healthy animals that attended the veterinary clinics during the four-month period, 
whose owners gave their informed consent to their animals’ participation, were 
included in this study. None of the animals had suffered from infections or had 
taken antibiotics during the three months prior to the sample collection. The age 
of the animals varied from 3 weeks to 10 years. All the animals tested were liv-
ing in different urban areas of Tunisia. 
Samples were inoculated in 3 ml of sterile saline solution, and an aliquot 
of 100 µl was seeded onto Slanetz-Bartley (SB) agar plates. These plates were 
incubated for 48 h at 37 °C. In order to study the diversity of enterococci in the 
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samples, we isolated one or two colonies per sample with a typical enterococcal 
morphology, they were identified by both classical biochemical methods and by 
PCR using primers specific for the different enterococcal species (Klibi et al., 
2013). If the two colonies belonged to the same species and presented the same 
phenotype of resistance, we selected only one for this study. All PCR reactions 
included positive and negative controls from the strain collection of the Univer-
sity of Tunis (Tunisia). 
Pulsed-field gel electrophoresis (PFGE) 
Genomic DNA of Enterococcus faecium strains was prepared as previ-
ously described (Klibi et al., 2013); one colony of the tested isolate was incu-
bated on 1 ml of Brain Heart Infusion Agar (BHIA) at 37 °C for 24 h, 200 µl of 
the suspension was centrifuged for 5 min at 8,000 rpm/min, and one ml of Tris-
EDTA (TE) was added to the precipitate. The suspension was then mixed with 
an equal volume of 2% pulsed-field certified agarose (Bio-Rad Laboratories) and 
poured into a mould to obtain the block. For restriction endonuclease digestion 
of the whole genomic DNA, small slices of agarose blocks were placed in a mix-
ture containing 88 µl of distilled water, 11 µl of 10 × reaction buffer and 10 U of 
SmaI (New England Biolabs). The preparations were incubated overnight at 25 °C. 
After digestion and washing, the blocks were placed in wells containing 1.2% 
pulsed-field-certified agarose gel made from 0.5 × Tris-borate-EDTA buffer. The 
gel was electrophoresed with a clamped homogeneous electric field using a 
CHEF-DR-III apparatus (Bio-Rad Laboratories). The total run time was 23 h, the 
switch time was 5 to 40 sec, and the voltage for the run was 6 V/cm. The gel was 
stained with ethidium bromide and photographed using a UV light source (Bio-
rad XR+). The resulting restriction patterns were analysed by visually and by 
GelCompar II software using the UPGMA algorithm and the Dice similarity co-
efficients (tolerance 1%) (Turabelidze et al., 2000). PFGE patterns were per-
formed twice for reproducibility. Lambda Ladder (BioLabs) was used as a PFGE 
marker. 
Antibiotic susceptibility testing 
Susceptibility testing was performed by the disc diffusion method for the 
following antimicrobial agents (µg per disc): vancomycin (30), teicoplanin (30), 
ampicillin (10), chloramphenicol (30), ciprofloxacin (5), tetracycline (30), eryth-
romycin (15), pristinamycin (15), linezolid (30), gentamicin (GEN, 500), kana-
mycin (KAN, 1000) and streptomycin (STR, 500) (CLSI, 2015). Minimal inhibi-
tory concentrations (MICs) of vancomycin, teicoplanin and linezolid were also 
determined by E-test method. The strain E. faecalis ATCC 29212 was used as 
quality control for all susceptibility tests. 
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Detection of antibiotic resistance genes by PCR 
The presence of antibiotic resistance genes was analysed by PCR in all en-
terococcal isolates using specific primers as previously described (Torres et al., 
2003; Klibi et al., 2013). The genomic DNA of enterococci was obtained with a 
commercial system (Instagene matrix, Biorad). The genes studied were as follow: 
aac(6’)-Ie-aph(2’’)-Ia, aph(3’)-IIIa, ant(6)-Ia, erm(A), erm(B), erm(C), mefA/E, 
msrA, tet(M), tet(L), tet(K), vat(D) and catpIP501. 
To characterise the mechanism of linezolid resistance, domain V region of 
the 23S rRNA gene, cfr gene and ribosomal proteins L3 and L4 were amplified 
and sequenced using primers previously described (Patel et al., 2013). Mutations 
affecting ribosomal proteins L3 and L4 were analysed by comparing the obtained 
sequences to those from wild-type S. epidermidis ATCC 12228, in addition to the 
ones of a linezolid-susceptible E. faecalis strain isolated during the same period. 
Production of gelatinase and haemolysin 
For the detection of gelatinase activity, enterococci were inoculated on 
tryptic soy agar plates containing 3% gelatin (Difco, Detroit, Michigan) which 
were then incubated at 37 °C for 24 h. Gelatinase activity was observed as a 
transparent halo around the colonies after the plate was flooded with Frazier so-
lution (Klibi et al., 2007). 
To investigate haemolysin production, isolates were streaked onto fresh 
horse blood agar plates and were grown overnight at 37 °C. A clear zone of beta 
haemolysis around the streak was considered to be a positive reaction for haemo-
lysin production.  
Detection of virulence genes by PCR 
Specific primers were used in this study for amplification by PCR of the 
genes which encode virulence factors (Klibi et al., 2007): esp [enterococcal sur-
face protein that plays a role in biofilm formation and adherence to abiotic sur-
faces (Shepard and Gilmore, 2002)]; ace [a collagen binding protein belonging to 
the microbial surface components recognising adhesive matrix molecules (Koch 
et al., 2004)]; cylA/cylB (cytolysin activator, cellular toxin capable of lysing a 
range of prokaryotic and eukaryotic cells), gelE (gelatinase, a zinc metalloprote-
ase with hydrolytic capacity of gelatin, collagen, casein, haemoglobin, and other 
biological peptides), and hyl (glycoside hydrolase, which acts on hyaluronic acid 
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Results and discussion 
A total of 58 enterococcal isolates were recovered from 18 of 20 cats and 
37 of 50 dogs, corresponding to one or two enterococci per positive sample. The 
distribution of species among the 58 enterococcal isolates was as follows: E. fae-
cium (31 isolates), E. faecalis (14 isolates), E. durans (6 isolates), E. hirae (2 iso-
lates), E. casseliflavus (3 isolates), and E. gallinarum (2 isolates). The detection 
of E. faecium and E. faecalis as the predominant enterococcal species shows 
strong similarities with data previously reported in the gut enterococcal microbi-
ota of pets and other animals (Poeta et al., 2007; Jackson et al., 2009; Silva et al., 
2012; Kataoka et al., 2014; Iseppi et al., 2015). 
Only two enterococcal species were detected in cats (E. faecium and E. 
faecalis). Other authors have detected E. faecium, E. hirae or E. avium as the 
predominant species in cats (Rodrigues et al., 2002; Jackson et al., 2009). For 
dogs, E. faecium was also the most prevalent species, followed by E. faecalis, E. 
durans, E. casseliflavus, E. gallinarum, and E. hirae. These findings are in ac-
cordance with results obtained in dogs in Portugal (Rodrigues et al., 2002; Poeta 
et al., 2006), although other studies performed in Denmark, the United States or 
Japan found E. faecalis as the most predominant enterococcal species in dogs 
(Damborg et al., 2008; Jackson et al., 2009; Kataoka et al., 2014). The number of 
animals included in the present study is limited, and more extensive studies 
should be performed in the future. 
The genetic diversity of the 31 E. faecium isolates recovered in this study 
from dogs and cats (the predominant species) was analysed by PFGE, using the 
SmaI restriction enzyme. Macrorestriction analysis by PFGE revealed a genomic 
diversity of the E. faecium under study, although there were four strains clonally 
related showing a similarity > 85% and differentiated in two PFGE groups, each 
consisting of two strains isolated from dogs or cats (Fig. 1). 
Table 1 shows the number of antimicrobial-resistant strains detected in our 
series of enterococcal isolates according to their origin. A large number of the 58 
tested strains showed resistance to erythromycin (n = 31) and tetracycline (n = 25). 
These antibiotics are used in dogs and cats for the treatment of a variety of infec-
tions, what could act as a selective pressure for this resistance phenotype (Jack-
son et al., 2009). Most of our erythromycin-resistant enterococci carried the 
erm(B) gene (22 of 31 isolates), which is in agreement with the findings of other 
studies, as erm(B) appears to be widespread among enterococci of animal origin 
(Jackson et al., 2010; Klibi et al., 2014). The erythromycin-resistant genes erm(A), 
erm(C), mefA/E and msrA were not detected in our erythromycin-resistant iso-
lates. 
The resistance to tetracycline was entirely explained by the presence of 
tet(M) gene in five isolates, by the combination of the tet(M) and tet(L) genes in 
16 isolates and by the detection of tet(L) in four isolates. The tet(M) gene was 
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the most frequent genetic determinant found in tetracycline-resistant enterococci 
by other authors (Jackson et al., 2010) and ourselves (Klibi et al., 2014). 
 
Fig. 1. Dendrogram based on SmaI-PFGE patterns. The GelCompar software (Applied Maths, 
Kortrijk, Belgium) was used to register macrorestriction patterns, and clustering analysis was  
performed using Dice similarity coefficient and the unweighted-pair group method with arithmetic 
mean (UPGMA) (tolerance 1% and optimisation 1%) 
 
Ampicillin resistance was detected in one E. faecium isolate recovered 
from a dog. This resistance in enterococci might be attributed either to β-
lactamase production or more probably to an increased production of penicillin-
binding protein PBP5 (Poeta et al., 2007). 
High-level resistance to streptomycin was ensured by the ant(6)-Ia gene in 
11 strains. High-level resistance to gentamicin is conferred by the aac(6’)-Ie-
aph(2’’)-Ia gene in 5 of 10 resistant strains, and high-level resistance to kanamy-
cin by aph(3’)-IIIa and/or aac(6’)-Ie-aph(2’’)-Ia genes in 11 of 15 resistant 
strains. These results correlate with the findings of similar studies in other re-
gions in the world (Poeta et al., 2006; Jackson et al., 2010). 
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Table 1 
Number of isolates showing antimicrobial resistance phenotypes in a series of 58 Enterococcus iso-
lates from pets (dogs and cats) 
Number of antimicrobial-resistant enterococci from pets 
Dogs (n = 39) Cats (n = 19) Total (n = 58) Antimicro-
bial agent 
E. faecium 
(n = 16) 
E. faecalis 
(n = 10) 
Others 
(n = 13) 
E. faecium
(n = 15) 
E. faecalis
(n = 4) 
Dogs 
(n = 39) 
Cats 
(n = 19) 
AMP 1 0 0 0 0 1 0 
ERY 9 8 5 8 1 22 9 
CIP 12 8 5 8 2 25 10 
PT 3 4 2 1 1 9 2 
STR 3 4 1 4 1 8 5 
KAN 3 4 3 4 1 10 5 
GEN 0 3 1 4 2 4 6 
TET 5 6 4 7 3 15 10 
CHL 2 1 1 2 2 4 4 
VAN 0 0 5c 0 0 5 0 
TEC 0 0 0 0 0 0 0 
LZ 0 3b 0 0 3d 3 3 
aAMP: ampicillin, ERY: erythromycin, CIP: ciprofloxacin, PT: pristinamycin, GEN: gentamicin, 
KAN: kanamycin, STR: streptomycin, TET: tetracycline, CHL: chloramphenicol, VAN: vancomy-
cin, TEC: teicoplanin, LZ: linezolid; bone strain with linezolid MIC of 8 µg/ml and two isolates 
with linezolid MIC of 4 µg/ml; cintrinsic resistance to vancomycin: E. casseliflavus (n = 3) and E. 
gallinarum (n = 2); dthree strains with linezolid MIC of 4 µg/ml 
 
Eight strains showed resistance to chloramphenicol, but only one strain 
harboured the cat(A) gene. Most of the strains showed resistance to ciprofloxacin 
(35/58, 60%), this resistance being associated most frequently with E. faecium; 
this percentage of resistance is higher than the one previously reported by other 
authors (Poeta et al., 2006; Delgado et al., 2007; Kataoka et al., 2014; Iseppi et 
al., 2015). Four of eleven pristinamycin-resistant strains (two E. faecium and two 
E. faecalis) harboured the vat(E) while one E. faecalis strain contained the vat(D) 
gene. 
Enterococcus gallinarum and E. casseliflavus isolates, with an intrinsic 
low-level vancomycin resistance and susceptibility to teicoplanin, were recov-
ered from five of the healthy dogs included in this study. The detection of en-
terococci with this type of glycopeptide intrinsic resistance, located on the chro-
mosome and not transferable to other bacteria, implicates a lower risk to public 
health. No acquired vancomycin resistance was identified among our isolates, 
which is similar to the findings of other studies (Damborg et al., 2008; Jackson et 
al., 2009; Kataoka et al., 2014; Iseppi et al., 2015). However, vanA enterococci 
have been identified in dogs in a previous study in Spain (Torres et al., 2003). In 
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Tunisia, vanA-mediated glycopeptide resistance has been sporadically reported 
in enterococci in the hospital setting (Abbassi et al., 2007; Elhani et al., 2014; 
Dziri et al., 2016), and also in birds (Klibi et al., 2015), but not in food-producing 
animals or healthy humans (Klibi et al., 2014; Ben Sallem et al., 2015). 
It is of interest to mention the presence of five E. faecalis strains which 
showed an MIC for linezolid of 4 µg/ml (intermediate susceptibility according to 
CLSI human breakpoints, although in the susceptible category according to 
EUCAST, 2015), and one additional E. faecalis strain with a linezolid MIC of 
8 µg/ml (resistant category in both CLSI 2015 and EUCAST 2015) (CLSI, 2015; 
EUCAST, 2015). Linezolid is an important antibiotic for the treatment of human 
infections by multidrug-resistant Gram-positive cocci. Our results indicate that 
enterococci with a low-level linezolid resistance might be emerging in Tunisia, 
after the drug has been licensed in human medicine and the surveillance of this 
resistance is required. Our sequence analysis results for the six E. faecalis iso-
lates with linezolid MIC of 4–8 µg/ml were negative for the mutation at nucleo-
tide position 2576 (G2576T) in domain V of the 23S rRNA. No other described 
mutations at positions 2503, 2504 and 2505 were found in these isolates (Patel et 
al., 2013). On the other hand, amino acid changes in ribosomal proteins L3 and 
L4, associated with decreased susceptibility to linezolid in staphylococci (Men-
des et al., 2012), were not detected among our enterococci. Moreover, the cfr 
gene was also not detected in our enterococci with increased MICs for linezolid. 
Therefore, other mechanisms of resistance could be implicated in the low-level 
linezolid resistance phenotype of our strains. It has been reported that a decrease 
in antimicrobial uptake, due to alterations in the permeability of the bacterial 
membrane or overexpression of an efflux system, may be implicated in linezolid 
resistance (Sierra et al., 2009). Alterations in ribosomal protein L22 have also 
been associated with increased resistance to linezolid (Tian et al., 2014). These 
possibilities will be evaluated in the future in our isolates. Few reports have men-
tioned the susceptibility of enterococci to linezolid in dogs and cats (Delgado et 
al., 2007; Jackson et al., 2009; Ghosh et al., 2012). 
Table 2 shows the different antimicrobial resistance phenotypes detected 
among our 58 enterococci from pets. In fact, multidrug resistance (MDR), defined 
as resistance to at least one agent in three or more antimicrobial categories, was 
observed in 8 strains (4 E. faecium, 2 E. faecalis, 1 E. casseliflavus and 1 E. hirae). 
This indicates that a small proportion of healthy pets could be carriers of anti-
microbial-resistant enterococci. The transmission of MDR enterococci from com-
panion animals might happen and the risk of this possibility should be assessed. 
One of the main concerns about enterococci is the presence of virulence 
factors that may contribute to the severity of infections. Seventeen of our entero-
coccal isolates exhibited gelatinase activity and harboured the gel(E) gene. This 
gene was also detected in four gelatinase-negative isolates, which finding might 
be explained by a deletion in the fsr operon (Nakayama et al., 2002; Klibi et al., 
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Table 2 
Antimicrobial resistance patterns in enterococci isolated from dogs and cats 
Pattern of antimicrobial resistancea Species (no isolates/type of animal)b 
LZI, GEN, KAN, STR, CHL, ERY, TET E. faecalis (1/c) 
LZ, GEN, KAN, ERY, TET, CIP  E. faecalis (1/d) 
KAN, STR, CHL, ERY, TET, CIP, PT E. faecium (1/d), E. casseliflavus (1/d) 
GEN, KAN, STR, ERY, TET, CIP E. faecium (1/c) 
GEN, KAN, ERY, TET, CIP, PT E. hirae (1/d) 
KAN, STR, CHL, ERY, TET, PT E. faecium (1/d) 
KAN, STR, CHL, ERY, TET, CIP  E. faecalis (1/d) 
LZI, GEN, CHL, TET, CIP  E. faecalis (1/c) 
GEN, KAN, STR, ERY, PT E. faecium (1/c) 
KAN, STR, ERY, CIP, AMP E. faecium (1/d) 
STR, ERY, TET, CIP  E. faecalis (1/d) 
LZI, GEN, KAN, STR, ERY E. faecalis (1/d) 
GEN, KAN, CHL, ERY  E. faecium (1/c) 
GEN, KAN, STR, ERY, CIP E. faecium (1/c) 
GEN, KAN, STR, ERY, TET E. faecalis(1/d) 
STR, CHL, ERY, TET E. faecium (1/c) 
ERY, TET, CIP  E. faecalis (1/d) 
LZI, ERY, TET  E. faecalis (1/d)  
ERY, TET, CIP  E. faecium (2/d, 1/c) 
ERY, CIP  E. faecalis (1/d)  
LZI, TET  E. faecalis (1/c) 
KAN, ERY E. durans (1/d) 
ERY, TET  E. faecium (1/c), E. casseliflavus (1/d) 
ERY, CIP E. faecium (3/d, 1/c), E. durans (1/d) 
ERY, PT E. faecium (1/d) 
TET, CIP E. faecium (1/d, 1/c), E. durans (1/d) 
TET  E. faecium (2/c), E. faecalis (1) 
CIP E. faecium(6), E. faecalis (1/c), E. durans (3/d),  
E. gallinarum (1/d), E. faecium (1/c) 
aLZ: linezolid, GEN: gentamicin, KAN: kanamycin, STR: streptomycin, CHL: chloramphenicol, 
ERY: erythromycin, TET: tetracycline, CIP: ciprofloxacin, PT: pristinamycin, AMP: ampicillin, 
LZI: intermediate resistance to linezolid. bType of animal: dog (d), cat (c) 
 
2007). The esp gene, that encodes an enterococcal surface protein associated 
with the ability to form biofilm onto abiotic surfaces (Klibi et al., 2007), was 
found in 6 E. faecalis, 3 E. faecium and 2 E. casseliflavus strains. The hyl gene 
was absent in all the collection and this gene is located on a megaplasmid which 
is widely distributed among clinically associated E. faecium isolates, and seems 
to be restricted to this species (Laverde Gomez et al., 2010). Five E. faecalis iso-
lates, which showed haemolytic activity, harboured the cylA and cylB genes. 
Haemolysin is a cytolytic protein capable of lysing human, horse and rabbit 
erythrocytes. Haemolysin-producing strains have been found to be associated 
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with increased severity of infections (Buma et al., 2006). The lack of apparent 
pathogenic potential of these isolates in healthy animals might be due to viru-
lence being multifactorial and associated with different genes. Further studies are 
needed to investigate the pathogenic role of virulence factors in animals. 
Enterococci are opportunistic organisms, and typically only cause clinical 
disease in patients when there is an underlying problem with local or systemic 
immunity, giving them the opportunity to thrive. It is possible that virulence fac-
tors would help cause disease in this type of situation, but not in healthy pets. We 
have very little evidence linking enterococcal virulence factors to disease in vet-
erinary patients. 
In conclusion, some pets in Tunisia may shed antimicrobial-resistant en-
terococci in their faeces, and more research is required to investigate the possibil-
ity of household contamination and risk of transmission to other household 
members. In addition, the close contact between pets and their owners highlights 
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